Literature DB >> 3500597

Effect of antiarthritic drugs on the enhanced interleukin-1 (IL-1) production by macrophages from adjuvant-induced arthritic (AA) rats.

M J DiMartino1, W J Johnson, B Votta, N Hanna.   

Abstract

The effect of antiarthritic drugs on hindpaw edema and enhanced IL-1 production by macrophages from adjuvant arthritic (AA) rats was determined. Hindpaw edema was inhibited by indomethacin (INDO), methotrexate (MTX) or prednisolone (PRED) but not by D-penicillamine (D-PEN) or chloroquine (CQ). IL-1 production by splenic adherent cells was decreased by MTX and PRED; whereas, IL-1 production by peritoneal exudate cells was decreased by PRED, INDO and D-PEN. This normalization in IL-1 production is not caused by a direct inhibition of IL-1 production by the drugs but most likely reflects clinical improvement in the disease. Whether reduction in IL-1 levels provides a more meaningful parameter than paw edema for assessing clinical efficacy of disease-modifying drugs remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3500597     DOI: 10.1007/BF01966512

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  5 in total

1.  Macrophage activation in rat models of inflammation and arthritis: determination of markers of stages of activation.

Authors:  W J Johnson; M J DiMartino; N Hanna
Journal:  Cell Immunol       Date:  1986-11       Impact factor: 4.868

Review 2.  Interleukin-1.

Authors:  C A Dinarello
Journal:  Rev Infect Dis       Date:  1984 Jan-Feb

3.  Cytokines and the chronic inflammation of rheumatic disease. I. The presence of interleukin-1 in synovial fluids.

Authors:  A M Nouri; G S Panayi; S M Goodman
Journal:  Clin Exp Immunol       Date:  1984-02       Impact factor: 4.330

4.  Macrophage activation in rat models of inflammation and arthritis. Systemic activation precedes arthritis induction and progression.

Authors:  W J Johnson; K A Muirhead; P C Meunier; B J Votta; T C Schmitt; M J DiMartino; N Hanna
Journal:  Arthritis Rheum       Date:  1986-09

5.  A modified assay for interleukin-1 (IL-1).

Authors:  P L Simon; J T Laydon; J C Lee
Journal:  J Immunol Methods       Date:  1985-11-28       Impact factor: 2.303

  5 in total
  7 in total

1.  Modulation of the IL-1 content by anti-inflammatory drugs during an acute non-specific inflammation.

Authors:  I Paegelow; H Werner
Journal:  Agents Actions       Date:  1989-01

2.  Differential effects of anti-arthritic agents on subnormal plasma iron levels in adjuvant arthritic rats.

Authors:  K M Connolly; V J Stecher; P T Speight; R Becker; J Rathman
Journal:  Agents Actions       Date:  1989-06

3.  Spontaneous release of angiotensin converting enzyme and interleukin 1 beta from peripheral blood monocytes from patients with rheumatoid arthritis under a serum free condition.

Authors:  M Goto; M Fujisawa; A Yamada; T Okabe; F Takaku; M Sasano; K Nishioka
Journal:  Ann Rheum Dis       Date:  1990-03       Impact factor: 19.103

Review 4.  Methotrexate--how does it really work?

Authors:  Edwin S L Chan; Bruce N Cronstein
Journal:  Nat Rev Rheumatol       Date:  2010-03       Impact factor: 20.543

5.  Suppression of pulmonary granulomatous inflammation by immunomodulating agents.

Authors:  M Hashimoto; K Kobayashi; N Yamagata; T Katsura; S Sugihara; H Iwabuchi; T Kasama; K Kasahara; T Takahashi; K Takeshita
Journal:  Agents Actions       Date:  1992-09

6.  Alteration of interleukin-1 activity and the acute phase response in adjuvant arthritic rats treated with disease modifying antirheumatic drugs.

Authors:  K M Connolly; V J Stecher; E Danis; D J Pruden; T LaBrie
Journal:  Agents Actions       Date:  1988-08

Review 7.  Molecular action of methotrexate in inflammatory diseases.

Authors:  Edwin S L Chan; Bruce N Cronstein
Journal:  Arthritis Res       Date:  2002-03-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.